Bharat Biotech Unveils Oral Cholera Vaccine Amid Global Shortage
Bharat Biotech International Ltd has launched Hillchol (BBV131), a novel single-strain oral cholera vaccine (OCV) developed under license from Hilleman Laboratories. This launch is critical as global demand for OCVs exceeds 100 million doses annually, and there has been a deficit of approximately 40 million doses due to limited supply.
With cholera cases and deaths rising since 2021, the need for OCVs has become more urgent. Currently, only one manufacturer supplies these vaccines worldwide, contributing to the significant shortfall.
Hillchol is administered orally on Day 0 and Day 14 and is suitable for individuals over one year of age. Available in a single-dose respule, the vaccine requires storage between +2°C and +8°C. Bharat Biotech’s manufacturing facilities in Hyderabad and Bhubaneswar can produce up to 200 million doses annually, aiming to address the global vaccine shortage.
The vaccine was developed through a collaboration between Hilleman Laboratories, Bharat Biotech, the University of Gothenburg, and Gotovax AB. The initiative aligns with the Global Task Force on Cholera Control’s (GTFCC) goal of reducing cholera-related deaths by 90% by 2030.
Founded: 1996
Headquarters: Hyderabad, India
Specialization: Vaccine development, production, and distribution
Notable Products: Covaxin (COVID-19 vaccine), Rotavac (rotavirus vaccine), Typbar TCV (typhoid vaccine), Hillchol (oral cholera vaccine)
Global Impact: Supplies vaccines to over 123 countries, known for pioneering affordable vaccines for global health
Research & Development: Focuses on innovative vaccine technologies, with partnerships in both public and private sectors
Manufacturing Capacity: State-of-the-art facilities with large-scale production capabilities, including a capacity of up to 200 million doses annually for Hillchol
Regulatory Approvals: Approved by major global health organizations, including WHO and national regulatory authorities
Recent Achievement: Launched Hillchol (BBV131), a novel oral cholera vaccine developed in collaboration with Hilleman Laboratories in 2024.
The Haryana State Assembly has unanimously passed a resolution to mark the 350th martyrdom year…
Every country has something special that makes it famous around the world. Some are known…
The United States and Jordan have carried out a major military operation in Syria called…
Jammu & Kashmir has achieved an important milestone in the modernization of public services with…
At the 2ndWHO Global Summit on Traditional Medicine held in New Delhi, Narendra Modi released…
Prime Minister Narendra Modi to inaugurate the new terminal building of Lokpriya Gopinath Bordoloi International…